Over 3,500 whooping cough cases were reported in the state last month, around four times the number reported for the same ...

Unpredictable communication and a lack of transparency are eroding the industry’s and the public’s trust. The FDA, experts ...

Following publication of KEYNOTE-689 Phase 3 results confirming the role of perioperative checkpoint inhibition in head and neck cancer, GeoVax announced plans for a Phase 2 trial (AdPNP-203) ...

More than three-quarters of American adults didn’t get a COVID shot last season, a figure that health care experts warn could ...

Younger Americans are more likely than older people to say these changes have influenced their decision. Among adults under 30 who are familiar with the CDC’s changes, about half say these changes ...

Among the most commonly cited reasons for COVID vaccine hesitation are fears about side effects, long-term health ...

Measles cases in the United States hit a 33-year high in 2025. And with cases reported in 42 states, many clinicians are ...

Niagen Bioscience, Inc. , the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the first-of-its-kind ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

About 1 in 4 American adults got a covid vaccine shot during the 2024-25 virus season, a fraction health care experts warn could be smaller this year as millions wrestle with conflicting advice from ...

The 38th annual Infectious Diseases in Children Symposium will address current events like outbreaks of measles and pertussis and changes to vaccine recommendations, among other hot topics in ...

Dr. Noc and other science communicators emphasize that credible information starts with qualified sources. Scientists, ...